Navigation Links
Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Date:4/23/2008

CAMBRIDGE, Mass., and MILAN, Italy, April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced preclinical data from the company's polymerase and protease inhibitor programs for the treatment of hepatitis C. These data are being presented at the Annual Meeting of the European Association for the Study of the Liver (EASL) being held this week in Milan, Italy.

Second-Generation Nucleoside Polymerase Inhibitor Program

IDX184 is a nucleotide prodrug derived from Idenix's proprietary liver- targeting technology. Results from in vitro and in vivo preclinical studies confirm that this technology preferentially activates IDX184 in the liver, potentially enhancing the antiviral activity of the drug and limiting systemic side effects. In an HCV replicon model, IDX184 exhibited 10 times greater potency than the first-generation HCV nucleoside clinical drug candidates currently in development. In HCV genotype-1 infected chimpanzees, once-daily oral administration of 10 mg/kg of IDX184 resulted in a mean viral load reduction of 2.3 log10 (n=5) after four days of dosing. No toxicities, including gastrointestinal or hematological, or abnormal blood chemistry were observed at oral doses greater than or equal to 600 mg/kg/day in a supporting seven-day toxicology study in cynomolgus monkeys.

IDX184 demonstrated additive antiviral activity in the HCV replicon in combination with HCV protease inhibitors and interferon and synergistic activity in combination with ribavirin. IDX184 also remained fully active in vitro against HCV containing known protease and non-n
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Auxilium Pharmaceuticals, Inc. ... today confirmed that Auxilium has received an unsolicited, non-binding ... ) to acquire all of the outstanding shares of ... share in cash and Endo stock, subject to due ... unsolicited, non-binding proposal that Auxilium received from Endo on ...
(Date:9/16/2014)... 2014 Hologic, Inc. (NASDAQ: ... Europa del Tomcat, un nuovo strumento preanalitico marcato ... completamente automatizzata, progettata per semplificare la fase preanalitica ... di errore legati alla gestione manuale dei campioni. ... Hologic riduce il carico di lavoro legato al ...
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
Breaking Medicine Technology:Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... CarePoint Partners (CarePoint) today announced that it has ... pharmacy services in Austin, Texas and infusion pharmacy ... area. The Austin location complements CarePoint,s Dallas and ... its southeastern footprint with this expansion into the ...
... Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Bank of America / ... 2011, in Las Vegas. The presentation is scheduled ... 11, 2011.  It will be available to all interested parties ...
Cached Medicine Technology:CarePoint Partners Expands Texas Presence and Opens Georgia Market With Acquisition of Premier Infusion 2
(Date:9/17/2014)... 2014 Health.Verticalize, a healthcare marketing company ... health insurance options in the 2014 open enrollment period, ... Moving forward Health Network will be using ... has intentionally remained out of the spotlight for the ... single website to its present position with dozens of ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... Although more and more people are being affected ... the true daily struggle of the disease. But one ... rob a person of their memory, it takes their ... Forget to Tell You ” (published by Xlibris) shares ... loved one who is suffering from Alzheimer’s disease. Her ...
(Date:9/16/2014)... 17, 2014 Top10BestSEOHosting.com has recently ... most recommended companies for the webmasters that want ... rates. , The senior spokesman for Top10BestSEOHosting.com ... Bluehost and HostMonster are the excellent hosting companies ... provide a wide range of advanced features while ...
(Date:9/16/2014)... Dog Food Secrets , a guide compiled by ... in most commercial dog food but presents a better alternative ... Shane Michaels, prompting an investigative review. , “For most ... member as any other human is, which is why it’s ... due to poor diet” reports Michaels. “Most dog owners don’t ...
Breaking Medicine News(10 mins):Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 3Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2
... ... , ... 24, 2010 -- At just over 18 pounds and with a sound level of only ... lighter and quieter than its battery-operated competitors. Powered by a lithium ion battery with 30 ...
... halt, expert says , TUESDAY, March 23 (HealthDay News) ... trials that are stopped early due to encouraging results, ... of 91 truncated trials with 424 comparable full-length trials, ... in particular, smaller studies -- reported exaggerated or misleading ...
... Walking, biking, dancing can all help normal-weight women as they ... An hour a day of moderate-intensity exercise will prevent weight ... a new study. , ",Moderate intensity, means brisk walking, casual ... Lee, lead author of the study, which is published in ...
... , BOSTON , March 23 ... current ESPN analyst Tedy Bruschi ... Trustees of Partners Continuing Care, the non-acute division of ... Partners Home Care, Partners Continuing Care offers the full ...
... America today hailed the "Patient Protection and Affordable Care Act" signed by the President today. The legislation will greatly expand access to mental health care ... ... , , ... ...
... , March 23 The Alzheimer,s Foundation of America issued the following statement on the health reform legislation that was signed into law today by President Obama:   , ... , ... ... ...
Cached Medicine News:Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2Health News:Abbreviated Trials Yield Misleading Results: Study 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 3Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 2Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 3Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 2Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: